Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.88)
# 53
Out of 5,123 analysts
36
Total ratings
76.47%
Success rate
47.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VSTM Verastem | Assumes: Buy | $18 | $6.28 | +186.62% | 1 | Feb 4, 2026 | |
| ERAS Erasca | Maintains: Buy | $11 → $15 | $11.88 | +26.26% | 2 | Jan 26, 2026 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $44 → $58 | $44.45 | +30.48% | 2 | Jan 26, 2026 | |
| IBRX ImmunityBio | Maintains: Buy | $8 → $10 | $5.64 | +77.30% | 8 | Jan 26, 2026 | |
| STRO Sutro Biopharma | Maintains: Neutral | $2 → $10 | $14.60 | -31.51% | 1 | Dec 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $10 → $4 | $0.61 | +560.07% | 1 | Dec 19, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Buy | $20 → $60 | $35.34 | +69.78% | 2 | Dec 9, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $6.50 | +253.85% | 2 | Dec 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $25 | $10.48 | +138.55% | 1 | Nov 24, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $0.91 | +668.89% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $20.15 | +98.51% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.39 | +441.27% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.29 | +334.78% | 1 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $105 | $56.88 | +84.60% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $49.20 | +52.44% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.86 | +182.17% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.36 | +310.45% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $17.24 | +16.01% | 1 | Aug 8, 2025 |
Verastem
Feb 4, 2026
Assumes: Buy
Price Target: $18
Current: $6.28
Upside: +186.62%
Erasca
Jan 26, 2026
Maintains: Buy
Price Target: $11 → $15
Current: $11.88
Upside: +26.26%
Scholar Rock Holding
Jan 26, 2026
Maintains: Buy
Price Target: $44 → $58
Current: $44.45
Upside: +30.48%
ImmunityBio
Jan 26, 2026
Maintains: Buy
Price Target: $8 → $10
Current: $5.64
Upside: +77.30%
Sutro Biopharma
Dec 22, 2025
Maintains: Neutral
Price Target: $2 → $10
Current: $14.60
Upside: -31.51%
Werewolf Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $10 → $4
Current: $0.61
Upside: +560.07%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $20 → $60
Current: $35.34
Upside: +69.78%
Protara Therapeutics
Dec 3, 2025
Reiterates: Buy
Price Target: $23
Current: $6.50
Upside: +253.85%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $25
Current: $10.48
Upside: +138.55%
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $0.91
Upside: +668.89%
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $20.15
Upside: +98.51%
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $7.39
Upside: +441.27%
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.29
Upside: +334.78%
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $56.88
Upside: +84.60%
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $49.20
Upside: +52.44%
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $8.86
Upside: +182.17%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.36
Upside: +310.45%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $17.24
Upside: +16.01%